Best Peptide Protocols
    Hormonal / Growth HormoneBlend

    4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 13mg blend: Dosage, Reconstitution & Research Protocol Guide

    Dosing ranges, reconstitution steps, administration details, cycle length, and storage guidance for 4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 (5mg/2.5mg/0.5mg/5mg Vial).

    Strength & Form:5mg/2.5mg/0.5mg/5mg Vial
    4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 (5mg/2.5mg/0.5mg/5mg Vial) peptide vial

    4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 (5mg/2.5mg/0.5mg/5mg Vial)

    13 mg blend Research Peptide

    Quick Facts

    Type
    Blend
    Category
    Hormonal / Growth Hormone
    Vial Strength
    13 mg blend
    Status
    Research

    Research Purposes Only

    This information is provided for educational purposes only. This content is not intended to diagnose, treat, cure, or prevent any disease. Always consult with qualified healthcare professionals.

    Download Guide

    Save the complete 4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 13mg blend research guide as a PDF.

    Educational and research use only. Not medical advice.

    Reference

    Sources used for this guide are listed in our research database .

    What Is 4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 13mg blend?

    4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 13mg blend Vial Overview

    This quad-peptide blend combines Tesamorelin (GHRH analog), Ipamorelin (selective GHSP), MGF (localized growth factor), and GHRP-2 (potent GH secretagogue). Each targets a distinct mechanism in the growth hormone cascade.

    4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 13mg blend Quick Reference

    4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 13mg blend Vial Specifications

    Peptide
    4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 (5mg/2.5mg/0.5mg/5mg Vial) (NNMT inhibitor)
    Vial Content
    Tesamorelin 5 mg + Ipamorelin 2.5 mg + MGF 0.5 mg + GHRP-2 5 mg per vial
    Category
    Hormonal / Growth Hormone
    Administration Method
    Subcutaneous injection
    Common Use Case
    Maximum GH axis activation — the most comprehensive GH blend available

    4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 13mg blend Compared With Other Formats

    Details that distinguish this 13 mg blend format include:

    • Four-peptide GH powerhouse
    • Dual GHRH + dual GHSP activation
    • Localized MGF + systemic GH optimization
    • Most aggressive GH protocol available

    How Does 4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 Work?

    4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 Mechanism of Action

    This quad-peptide blend activates every major pathway in the GH axis: Tesamorelin (full-length GHRH analog) + GHRP-2 (most potent ghrelin agonist) for maximum dual-receptor GH release, Ipamorelin (selective GHS-R) for clean baseline GH elevation, and MGF (localized IGF-1 splice variant) for satellite cell activation. This is the most comprehensive GH optimization stack available.

    What Are the Potential Benefits of 4X – Tesamorelin + Ipamorelin + MGF + GHRP-2?

    4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 Research Findings and Observed Outcomes

    Findings and reported areas of study for 4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 (5mg/2.5mg/0.5mg/5mg Vial) include:

    • Maximum GH amplitude
    • Multi-receptor GH axis activation
    • Localized muscle growth factor signaling
    • Visceral fat reduction (Tesamorelin)
    • Significant IGF-1 elevation
    • Enhanced body composition

    These observations are discussed for research and educational reference only and are not medical claims.

    What Do You Need to Reconstitute 4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 13mg blend?

    4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 13mg blend Supplies for Reconstitution and Handling

    • •4X GH blend vial (13 mg)
    • •Bacteriostatic water
    • •3 mL mixing syringe with 21g needle
    • •U-100 insulin syringes (29–31g)
    • •Alcohol swabs

    Supplies listed are for laboratory handling and research preparation purposes only.

    4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 13mg blend Administration and Research Protocol

    4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 Injection Route, Frequency and Timing

    RouteSubcutaneous injection
    Frequency1–2 times daily
    TimingPre-bed (primary) and/or post-workout

    Must be fasted. Expect appetite stimulation from GHRP-2 component. This is an advanced protocol.

    4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 13mg blend Dosage Guide

    4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 Dosage Ranges

    The ranges below pair the listed dose with the draw volume for this product strength.

    Low Range300 mcg total blend
    Standard Range500 mcg total blend
    Upper Range1 mg total blend

    4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 13mg blend Dosage to Syringe Units

    Based on reconstitution below

    Target Daily DoseDraw VolumeUnits
    300 mcg0.05 mL5 units
    500 mcg0.08 mL8 units
    1 mg0.15 mL15 units

    This dosing table is unique to the 13 mg blend vial. Units refer to markings on a standard U-100 insulin syringe (1 unit = 0.01 mL).

    How Long Does a 4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 13mg blend Vial Last?

    4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 13mg blend Duration by Research Dose

    At common research doses, one 13 mg blend vial of 4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 typically supports:

    300 mcg total blend8–12 weeks
    500 mcg total blend8 weeks
    1 mg total blend6 weeks

    How to Reconstitute 4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 13mg blend

    4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 13mg blend Reconstitution With Bacteriostatic Water

    This section applies specifically to the 4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 (5mg/2.5mg/0.5mg/5mg Vial).

    Recommended Diluent
    Bacteriostatic water (BAC water)
    Diluent Volume
    2 mL
    Final Concentration
    6.5 mg/mL total blend

    4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 13mg blend Mixing Instructions

    1. 1Remove the vial from storage and allow it to reach room temperature (10–15 minutes).
    2. 2Wash hands thoroughly and prepare a clean workspace with all supplies.
    3. 3Using a sterile syringe, draw the appropriate volume of bacteriostatic water.
    4. 4Clean the rubber stopper of the vial with an alcohol prep pad.
    5. 5Insert the needle at a slight angle and slowly inject the diluent down the inner wall of the vial.
    6. 6Gently swirl or roll the vial until fully dissolved; the solution should appear clear and colorless.
    7. 7Label the vial with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light. Use within 2–4 weeks.

    4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 Stacks and Research Combinations

    4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 and Compatible Research Pairings

    In research settings, 4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 (5mg/2.5mg/0.5mg/5mg Vial) is sometimes paired with peptides such as:

    This is already the most aggressive GH stack. Do NOT add additional GH-axis peptides. Recovery peptides only.

    Factors That May Affect 4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 Research Outcomes

    Supporting Factors for 4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 Research

    Factors recorded alongside this protocol include:

    • Strict fasting protocol around injections
    • Intensive resistance training program
    • High protein intake (1.5 g/lb)
    • 8+ hours sleep
    • Monitor for cortisol and prolactin effects

    These factors can affect how research observations are interpreted.

    4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 Side Effects and Safety Considerations

    4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 13mg blend Tolerability Notes

    Most side effects of any GH blend due to quad-peptide potency

    Some individuals report:

    • Strong appetite stimulation (GHRP-2)
    • Water retention
    • Cortisol and prolactin elevation
    • Tingling, flushing, warmth
    • Joint stiffness
    • Vivid dreams
    • Transient numbness in extremities

    How to Store 4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 Before and After Reconstitution

    4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 13mg blend Storage Requirements

    Unreconstituted
    Refrigerate (2–8°C)
    Reconstituted
    Refrigerate (2–8°C)
    Post-Mix Stability
    Use within 21 days — contains fragile peptides

    Who Should Avoid 4X – Tesamorelin + Ipamorelin + MGF + GHRP-2?

    This peptide is generally not recommended for:

    • Those new to GH secretagogues (start with CJC + Ipamorelin)
    • Those with elevated prolactin
    • Those with active cancer
    • Pregnant or breastfeeding individuals
    • Those with pituitary disorders

    4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 13mg blend FAQs

    Is this blend for beginners?

    No — this is the most advanced GH secretagogue combination available. Start with CJC-1295 + Ipamorelin to assess tolerance before progressing to multi-peptide GH protocols.

    Why combine two GHSPs (Ipamorelin + GHRP-2)?

    They have different receptor binding profiles and selectivity. Ipamorelin provides clean, steady GH elevation while GHRP-2 adds maximum GH amplitude. The combination achieves broader GH-axis coverage.

    Where to Buy 4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 13mg blend for Research

    4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 13mg blend Purchasing and Research Supply Notes

    Before ordering 4X – Tesamorelin + Ipamorelin + MGF + GHRP-2 (5mg/2.5mg/0.5mg/5mg Vial), review the product label, available testing documents, and storage instructions.

    Check the ResearchLabs listing for:

    • Available testing documents
    • Product strength and concentration
    • Storage and handling instructions
    • Current product availability

    Confirm the product strength and storage requirements before ordering. Products are for laboratory research only and are not for human consumption.

    Related Hormonal / Growth Hormone Peptides

    CJC-1295 No DAC (5 mg Vial) productCJC-1295 No DAC (5 mg Vial)CJC-1295 DAC (5 mg Vial) productCJC-1295 DAC (5 mg Vial)GHRP-2 (5 mg Vial) productGHRP-2 (5 mg Vial)GHRP-6 (5 mg Vial) productGHRP-6 (5 mg Vial)Hexarelin (5 mg Vial) productHexarelin (5 mg Vial)IGF-1 LR3 (1 mg Vial) productIGF-1 LR3 (1 mg Vial)